Evidence-Based Oncology > July 2018
Evidence-Based Oncology - July 2018
July 18, 2018 – Surabhi Dangi-Garimella, PhD
Results presented at the 2018 American Society of Clinical Oncology's Annual Meeting found that transoral robotic-assisted surgery (TORS), following chemotherapy and neck resections, is an effective model for the definitive treatment for oropharyngeal squamous cell carcinoma (OPSCC) while avoiding the adverse effects of radiation.
July 25, 2018 – Kelly Davio
During the 2018 American Society of Clinical Oncology’s (ASCO) Annual Meeting, researchers presented findings on 3 biosimilar trastuzumab products: Samsung Bioepis’ SB3, Agmen’s ABP 980, and Biocad’s Herticad.
July 25, 2018
Clinical findings as presented at the American Society of Clinical Oncology's Annual Meeting in June 2018.
July 26, 2018 – Reporting by Surabhi Dangi-Garimella, PhD, and Jaime Rosenberg
Care strategies updates from the American Society of Clinical Oncology's Annual Meeting, held June 2018.
July 26, 2018 – Reporting by Jaime Rosenberg, Mary Caffrey, Kelly Davio, and Christine Potkul
July 26, 2018 – Reporting by Samantha DiGrande
July 26, 2018 – Produced by Samantha DiGrande and Jaime Rosenberg
AJMC®TV interviews let you catch up on what’s new and important about changes in healthcare, with insights from key decision makers—from the clinician, to the health plan leader, to the regulator. When every minute in your day matters, AJMC®TV interviews keep you informed. Access the video clips at ajmc.com/interviews.
July 26, 2018
CAR T-Cell therapy updates presented at the American Society of Clinical Oncology's Annual Meeting held June 2018.